Unravelling druggable signalling networks that control F508del-CFTR proteostasis
about
CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisIdentification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutantsThymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisCFTR pharmacology.Identifying new antiepileptic drugs through genomics-based drug repurposing.Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer
P2860
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@ast
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@en
type
label
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@ast
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@en
prefLabel
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@ast
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@en
P2093
P2860
P50
P356
P1433
P1476
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
@en
P2093
Advait Subramanian
Diego Carrella
Francesco Iorio
Graeme Carlile
Laura Bounti
Maria Persico
P2860
P356
10.7554/ELIFE.10365
P407
P50
P577
2015-12-23T00:00:00Z